UPDATE: Americans Want FDA to End Peptide Roulette, New National Poll Finds
PR Newswire
PONTE VEDRA BEACH, Fla., July 21, 2026
In the news release, Americans Want FDA to End Peptide Roulette, New National Poll Finds, issued 21-Jul-2026 by Peppies, LLC over PR Newswire, we are advised by the company that hyperlinks missing from the original release have been added. The complete, corrected release follows: A majority of Americans support legal peptide access through a U.S. pharmacy and doctor's prescription; just 3% are opposed, and nearly half remain undecidedPONTE VEDRA BEACH, Fla., July 21, 2026 /PRNewswire/ -- A new national survey of 1,000 adults finds that 52% feel they should be able to obtain peptides through a licensed U.S. pharmacy with a doctor's prescription, while only 3% oppose, and 45% are currently not sure. Among those expressing an opinion (55% of adults), adult access is favored by a 19 to 1 ratio. The poll, conducted by Mason-Dixon Polling & Strategy and commissioned by the peptide-education resource Peppies.com, lands days before the FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to consider whether seven peptides should regain a lawful compounding pathway.
